The m6A regulators in prostate cancer: molecular basis and clinical perspective
Prostate cancer (PCa) is the second leading cause of cancer-related death among men in western countries. Evidence has indicated the significant role of the androgen receptor (AR) as the main driving factor in controlling the development of PCa, making androgen receptor inhibition (ARI) therapy a pi...
Saved in:
Main Authors: | Yu Cao (Author), Man Jia (Author), Chunyan Duan (Author), Zhihui Yang (Author), Bo Cheng (Author), Ronghao Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents
by: Bingke Bai, et al.
Published: (2021) -
The Molecular Basis of Adenomyosis Development
by: Woo Sub Yang, et al.
Published: (2018) -
Epigenetic Regulations of Inflammatory Cyclooxygenase-Derived Prostanoids: Molecular Basis and Pathophysiological Consequences
by: Hedi Harizi
Published: (2015) -
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
by: Ola Sobhy A. Elmeseiny, et al.
Published: (2024) -
Insights into the molecular basis of tick-borne encephalitis from multiplatform metabolomics.
by: YanDan Du, et al.
Published: (2021)